Log In
Print this Print this

TKI Implant

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionIntraocular implant which includes tyrosine kinase inhibitor and biodegradable polymer
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today